« Home
These Terms and Conditions govern your use of our website. By using our website, you agree to these Terms and Conditions in full. If you disagree with these Terms and Conditions or any part of these Terms and Conditions, you must not use our website. We do not recognise any conflicting or differing terms and conditions – unless we have specifically agreed otherwise in writing.
You must be at least 18 years of age to use our website. By using our website and by agreeing to these Terms and Conditions, you warrant and represent that you are at least 18 years of age.
Our website uses cookies. By using our website and agreeing to these Terms and Conditions, you consent to our use of cookies in accordance with the terms of our privacy policy.
These Terms and Conditions may be updated at any time. If a meaningful change is made to the Terms and Conditions, you will be informed via a notification on this website. As such, please review the Terms and Conditions on a regular basis as you are responsible for regularly reviewing our website to ensure prompt notification of any updates to our Terms and Conditions.
Please note that if you continue to use the website after the Terms and Conditions have been updated, your continued use will act as notification and acceptance of any changes. Therefore, if you do not agree to the changes, you should immediately stop using the website.
The Terms and Conditions that apply to your use of our website are those that are in force at the time of accessing or using our website; unless any changes to these Terms and Conditions are required to be made by law or governmental authority. In such cases, the Terms and Conditions that apply are those to the extent that such changes have retrospective effect in law.
The following Terms and Conditions will continue, even after your user access expires or is cancelled:
All copyrights, proprietary rights and other third-party rights to the website and its content remain the sole property of their respective holders and are protected accordingly. Subject to the licence below, all these intellectual property rights are reserved.
You may view, download for caching purposes only, and print pages from the website for your own personal use, subject to the restrictions set out below and elsewhere in these Terms and Conditions.
You must not
You may use the website, content, and services for lawful, personal, non-commercial purposes only as described in these Terms and Conditions.
You must not use our website in any way that causes, or may cause, damage to the website or impairment of the availability or accessibility of the website; or in any way which is unlawful, illegal, fraudulent or harmful, or in connection with any unlawful, illegal, fraudulent or harmful purpose or activity.
You must not use our website to copy, sell, resell, store, host, transmit, send, use, publish or distribute any material which consists of (or is linked to) any spyware, computer virus, Trojan horse, worm, keystroke logger, rootkit or other malicious computer software.
You must not conduct any systematic or automated data collection activities (including, without limitation, scraping, data mining, data extraction and data harvesting) on or in relation to our website without our express written consent.
You must not use our website to transmit or send unsolicited commercial communications.
You must not use our website for any purposes related to marketing without our express written consent.
Access to certain areas of our website is restricted. We reserve the right to restrict access to other areas of our website, or indeed our whole website, at our discretion.
If we provide you with or you generate a user ID and password to enable you to access restricted areas of our website or other content or services, you must ensure that the password is kept secure and confidential.
You must notify us in writing immediately if you become aware of any unauthorised use of your account or password.
You are responsible for any activity on our website arising out of any failure to keep your password confidential and may be held liable for any losses arising out of such a failure.
You must not use any other person’s user ID and password to access our website.
We may disable your user ID and password at any time in our sole discretion with or without notice or explanation.
We may, at any time and from time to time, add to, replace, modify or discontinue, temporarily or permanently, the website with or without notice.
We may cancel or suspend your access to the website with immediate effect in our sole discretion and without notice if you breach these Terms and Conditions. We will remove any material that violates these Terms and Conditions or our Privacy Notice.
In these Terms and Conditions, “your content” means any material (including, without limitation, text, images, audio material, video material and audio-visual material) that you submit to our website, for whatever purpose.
You grant our partners a worldwide, irrevocable, non-exclusive, royalty-free licence to use, reproduce, adapt, publish, translate and distribute your content in any existing or future media. You also grant to us the right to sub-license these rights and the right to bring an action for infringement of these rights.
You warrant and represent that your content will comply with these Terms and Conditions.
Your content must not be offensive, obscene, illegal, unlawful or an infringement of a third party’s legal rights and must not be capable of giving rise to legal action whether against you or us or a third party (in each case under any applicable law).
You must not submit any content to the website that is or has ever been the subject of any threatened or actual legal proceedings or other similar complaint.
We reserve the right to edit or remove any material submitted to our website, or stored on our servers, or hosted or published upon our website.
Notwithstanding our rights under these Terms and Conditions in relation to your content, we do not undertake to monitor the submission of such content to, or the publication of such content on, our website.
We do not warrant the completeness or accuracy of the information published on this website nor do we commit to ensuring that the website remains available or that the material on the website is kept up to date. In particular, we do not warrant that the functions contained in the material contained in this website will be uninterrupted or error free, that defects will be corrected, or that this website or the server that makes it available are free of viruses or bugs or represents the full functionality, accuracy, and reliability of the materials.
As far as information and products offered by third-party businesses and individuals are concerned, we only provide the technical platform. Such content or offers made available to you by third parties are property of their respective creators, authors or distributors and not ours. Therefore, for the avoidance of doubt, we are under no circumstances responsible for the accuracy or reliability of such content, information or offerings. In particular, except as set out in these Terms and Conditions, we accept no liability for any loss or damage you may incur through reliance on such information.
To the maximum extent permitted by applicable law, we exclude all representations, warranties and conditions relating to this website and the use of this website (including, without limitation, any warranties implied by law in respect of satisfactory quality, fitness for purpose and/or the use of reasonable care and skill).
Nothing in these Terms and Conditions will: (a) limit or exclude our or your liability for death or personal injury resulting from negligence; (b) limit or exclude our or your liability for fraud or fraudulent misrepresentation; (c) limit any of our or your liabilities in any way that is not permitted under applicable law; or (d) exclude any of our or your liabilities that may not be excluded under applicable law.
The limitations and exclusions of liability set out in this section and elsewhere in these Terms and Conditions: (a) are subject to the preceding paragraph; and (b) govern all liabilities arising under these Terms and Conditions or in relation to the subject matter of these Terms and Conditions, including liabilities arising in contract, in tort (including negligence) and for breach of statutory duty.
To the extent that the website and the information and services on the website are provided free of charge, we will not be liable for any loss or damage of any nature.
We will not be liable to you in respect of any losses arising out of any event or events beyond our reasonable control.
We will not be liable to you in respect of any business losses, including (without limitation) loss of or damage to profits, income, revenue, use, production, anticipated savings, business, contracts, commercial opportunities or goodwill.
We will not be liable to you in respect of any loss or corruption of any data, database or software.
We will not be liable to you in respect of any special, indirect or consequential loss or damage.
You hereby indemnify us and undertake to keep us indemnified against any losses, damages, costs, liabilities and expenses (including, without limitation, legal expenses and any amounts paid by us to a third party in settlement of a claim or dispute on the advice of our legal advisers) incurred or suffered by us arising out of any breach by you of any provision of these Terms and Conditions, or arising out of any claim that you have breached any provision of these Terms and Conditions.
Without prejudice to our other rights under these Terms and Conditions, if you breach these Terms and Conditions in any way, we may take such action as we deem appropriate to deal with the breach, including suspending your access to the website, prohibiting you from accessing the website, blocking computers using your IP address from accessing the website, contacting your internet service provider to request that they block your access to the website or bringing court proceedings against you.
We may revise these Terms and Conditions from time to time. Revised Terms and Conditions will apply to the use of our website from the date of publication of the revised Terms and Conditions on our website.
We may transfer, sub-contract or otherwise deal with our rights or obligations under these Terms and Conditions without notifying you or obtaining your consent.
You may not transfer, sub-contract or otherwise deal with your rights or obligations under these Terms and Conditions.
If a provision of these Terms and Conditions is determined by any court or other competent authority to be unlawful and/or unenforceable, the other provisions will continue in effect. If any unlawful and/or unenforceable provision would be lawful or enforceable if part of it were deleted, that part will be deemed to be deleted, and the rest of the provision will continue in effect.
These Terms and Conditions are for the benefit of you and us, and are not intended to benefit any third party or be enforceable by any third party. The exercise of our and your rights in relation to these Terms and Conditions is not subject to the consent of any third party.
These Terms and Conditions, together with our privacy policy and cookies policy, constitute the entire agreement between you and us in relation to your use of our website and supersede all previous agreements in respect of your use of our website.
These Terms and Conditions will be governed by and construed in accordance with English law, and any disputes relating to these Terms and Conditions will be subject to the exclusive jurisdiction of the courts of England and Wales.
The full name of our company is Springer Healthcare Limited.
We are registered in England and Wales under registration number 06032554.
Our registered address is The Campus, 4 Crinan Street, London N1 9XW.
You can contact us by email to moc/regnirps//EMI
This policy was last updated on December 13, 2021.
« Home
This activity is supported by independent educational grants from Roche and Illumina.
Email: moc/regnirps//emi
Springer Healthcare IME
The Campus, 4 Crinan Street, London, N1 9XW, UK
© 2024 Springer Healthcare IME, part of Springer Nature Group
Jaime L. Schneider, MD, PhD, is a medical oncologist at the Massachusetts General Hospital (MGH) Cancer Center specializing the care of patients with thoracic malignancies. Dr. Schneider received her B.A. at Northwestern University and her MD/PhD from the Albert Einstein College of Medicine as part of the Medical Scientist Training Program.
She trained as an internal medicine resident at MGH in Boston, MA as part of the Stanbury Physician-Scientist Pathway. She then completed medical oncology fellowship in the Dana-Farber Cancer Institute/Harvard Cancer Care program. She joined faculty at the MGH Cancer Center and has an active practice caring for patients in the Thoracic Oncology Program.
Jaime L. Schneider, MD, PhD, is also a research scientist at Harvard Medical School where her research is focused on using integrative metabolomics approaches to uncover resistance mechanisms to improve the care of lung cancer patients.
Disclosures
Grant Support
Lung cancer research foundation/ALK positive; A breath of hope lung foundation
Speakers Bureau
Dava Oncology
Consultant/Advisory Board
Cadence CR
Solange Peters, MD, PhD, is a full professor, and chair of medical oncology and the thoracic malignancies programme in the Department of Oncology at the University Hospital of Lausanne in Lausanne, Switzerland. She received both her doctorate in medicine and PhD from the University Hospital of Lausanne. After completing her clinical education in medical oncology and molecular biology in Switzerland and Italy, Prof. Peters specialised in thoracic tumours, lung cancer, and pleural tumours.
Solange Peters, MD, PhD, is currently in charge of teaching and patient care in thoracic malignancies at Lausanne University, where she is building a translational programme in collaboration with the Swiss Federal Institute of Technology and the Ludwig Institute. Her main fields of interest are new biomarker discovery and validation in preclinical and clinical settings, multimodality strategies for locally advanced non-small cell lung cancer (NSCLC), as well as cancer immunotherapy. Her current research projects are mainly focused on innovative immunotherapy combinations and new immunomodulating treatments across thoracic malignancies. She acts as the local principal investigator (PI) for lung trials opened at Lausanne Cancer Centre and is a co-PI of several other trials. Additionally, she acts as the scientific committee chair and Foundation Council member of the European Thoracic Oncology Platform. She was recently nominated as the Strategic Advisory Board President of the Paris Saclay Cancer Cluster and is part of the Board of Directors of the Swiss National Cancer League.
Prof. Peters has authored more than 500 peer-reviewed manuscripts and book chapters, acts as Associate Editor of the Annals of Oncology, Deputy Editor of Lung Cancer, and serves on the editorial board of several other oncology journals. She was the deputy editor of the Journal of Thoracic Oncology for 10 years. Prof. Peters is active in the educational programmes of the European Society for Medical Oncology (ESMO), where she created the Women for Oncology Committee and for which she was the youngest President ever for an extended time of 3 years 2020-2022, and the International Association for the Study of Lung Cancer (IASLC), where she was a member of the Board of Directors
Disclosures
Grant support
(institutional financial support for clinical trials) sponsored by Amgen, Arcus, AstraZeneca, Beigene, Bristol-Myers Squibb, GSK, iTeos, Merck Sharp and Dohme, Mirati, Pharma Mar, Promontory Therapeutics, Roche/Genentech, Seattle Genetics.
Speakers Bureau
AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Foundation Medicine, GSK, Illumina, Ipsen, Merck Sharp and Dohme, Mirati, Novartis, Pfizer, Roche/Genentech, Sanofi, Takeda.
Consulting / Advisory board
AbbVie, Amgen, Arcus, AstraZeneca, Bayer, Beigene, BerGenBio, Biocartis, BioInvent, Blueprint Medicines, Boehringer Ingelheim, Bristol-Myers Squibb, Clovis, Daiichi Sankyo, Debiopharm, Eli Lilly, F-Star, Fishawack, Foundation Medicine, Genzyme, Gilead, GSK, Hutchmed, Illumina, Incyte, Ipsen, iTeos, Janssen, Merck Sharp and Dohme, Merck Serono, Merrimack, Mirati, Nykode Therapeutics, Novartis, Novocure, Pharma Mar, Promontory Therapeutics, Pfizer, Regeneron, Roche/Genentech, Sanofi, Seattle Genetics, Takeda.
Board of Director position
Galenica
Lizza Hendriks, MD, PhD, is a pulmonologist specialising in thoracic oncology at the Maastricht University Medical Center, the Netherlands, where she leads the clinical lung cancer research department. Her research line is focussing on brain metastases in patients with lung cancer, neurocognition, oligometastases and locally advanced disease. In 2017-2018, she carried out postdoctoral research on brain metastases and immunotherapy in Gustave Roussy, France under the mentorship of Prof. Besse.
Lizza Hendriks, MD, PhD, is the representative for thoracic oncology in the Maastricht UMC Comprehensive Cancer Cancer, and chairs the Innovative Cancer Diagnostics Therapy group at the School for Oncology and Developmental Biology (GROW) at Maastricht University, where she is also appointed as assistant professor. She is heavily involved in clinical and translational research, and is (local) principal investigator in several phase II and III clinical trials, focusing on (locally) advanced NSCLC and SCLC, targeted treatments and immunotherapies.
She is an active member of Dutch (NVALT, NRS), European (ESMO, EORTC, ETOP, ERS) and global societies (IASLC, ASCO), is secretary of the NVALT studies foundation, vice-chair of the scientific committee of the Dutch Thoracic Group and chairs the EORTC sub-committee on Systemic Treatment for metastatic NSCLC.
Lizza Hendriks, MD, PhD, was the lead author of the revised ESMO Clinical Practice Guidelines on metastatic NSCLC and author of the ESMO Clinical Practice Guideline on SCLC. She is member of the Dutch guideline committees on NSCLC, brain metastases and leptomeningeal metastases. Dr Hendriks is an active program committee member or chair of several national and international conferences and masterclasses. In 2021, she was elected as member of the Young Academy of the Royal Netherlands Academy of Arts and Sciences.
Disclosures
Consulting / Advisory board
(Paid to Institution) Roche/Genentech, Lilly, Pfizer, Takeda, Boehringer Ingelheim, AstraZeneca, MSD, Amgen, Janssen, Novartis, Anheart Therapeutics, Merck
Speakers’ Bureau
Medtalks, Benecke, high5oncology, Medimix, VJOncology.
(Paid to Institution) MSD, Bayer, Lilly, AstraZeneca, Takeda, GSK, Sanofi, Pfizer
Grant Support
(Institutional financial support) Roche/Genentech, AstraZeneca, Boehringer Ingelheim, Takeda, Merck, Novartis, Pfizer, Gilead